These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis. Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis. Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079 [TBL] [Abstract][Full Text] [Related]
25. Transport kinetics of pseudouridine during hemodialysis and continuous ambulatory peritoneal dialysis. Struijk DG; Schoots AC; Koole LH; van der Reijden HJ; Koomen GC; Krediet RT; Arisz L J Lab Clin Med; 1991 Jul; 118(1):74-80. PubMed ID: 2066647 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis. Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427 [TBL] [Abstract][Full Text] [Related]
34. The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol. Daneshmend TK; Roberts CJ Br J Clin Pharmacol; 1982 Jul; 14(1):73-8. PubMed ID: 7104169 [TBL] [Abstract][Full Text] [Related]
35. Disposition of cefmetazole in healthy volunteers and patients with impaired renal function. Halstenson CE; Guay DR; Opsahl JA; Hirata CA; Olanoff LS; Novak E; Ko H; Cathcart KS; Matzke GR Antimicrob Agents Chemother; 1990 Apr; 34(4):519-23. PubMed ID: 2344159 [TBL] [Abstract][Full Text] [Related]
36. Plasma levels of human atrial natriuretic factor in patients treated by hemodialysis and continuous ambulatory peritoneal dialysis. Ando R; Matsuda O; Miyake S; Yoshiyama N Nephron; 1988; 50(3):225-8. PubMed ID: 2976122 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Hampson G; Vaja S; Evans C; Chesters CA; Pettit R; Evans W; Thomas D; Seed PT; Fraser WD Nephron; 2002 May; 91(1):94-102. PubMed ID: 12021525 [TBL] [Abstract][Full Text] [Related]
38. [The effect of the number of peritonitis episodes on peritoneal membrane function]. Jovanović D; Nesić V; Dimitrijević Z Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837 [TBL] [Abstract][Full Text] [Related]
39. Continuous i.v. infusion of labetalol for postoperative hypertension. Haemodynamic effects and plasma kinetics. Chauvin M; Deriaz H; Viars P Br J Anaesth; 1987 Oct; 59(10):1250-6. PubMed ID: 3676053 [TBL] [Abstract][Full Text] [Related]
40. Cefotaxime and metabolite disposition in two pediatric continuous ambulatory peritoneal dialysis patients. Paap CM; Nahata MC; Mentser MA; Mahan JD; Puri SK; Hubbard JA Ann Pharmacother; 1992 Mar; 26(3):341-3. PubMed ID: 1554953 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]